Original filing (PDF)20251002094407NAL0000262465001

ALGENOL U.S. INC

Name: ALGENOL U.S. INC — ALGENOL U.S. INC 401(K), Form 5500 (2024)
Creator: ALGENOL U.S. INC

Form 5500-SF

FILING_RECEIVED

ALGENOL U.S. INC 401(K)

401(k) retirement plan

Active participants

Accounts w/ balance

Plan assets (EOY)

$6.6M

Net assets (EOY)

$6.6M

Plan health score (directional)

/ 100

Grade A

Top-tier plan health

Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.

Compliance & disclosures

100

Concentration risk

Total plan cost

Vendor stack

100

Participation health

Decision-maker contacts

CFO / Head of HR / Benefits Manager — verified email + LinkedIn for ALGENOL U.S. INC.

Plan sponsor

Name

ALGENOL U.S. INC

EIN

03-0591679

Address

16151 LEE ROAD · FORT MYERS, FL · 33912

Phone

(239) 498-2000

Industry

Professional & Technical Servicessee all

Plan administrator

Same as plan sponsor.

Plan characteristics

Plan number

001

Plan year

2024

Plan year begin

2024-01-01

Tax period

2024-12-31

Filed

2025-10-02

Pension benefit codes

2A · Age/service weighted or new comparability

2E · Profit-sharing

2F · ERISA section 404(c)

2G · Total participant-directed accounts

2J · 401(k) feature

2K · 401(m) arrangement

2S · Automatic enrollment

2T · Default investment account (QDIA)

Service providers (Schedule C)

Small plans don't disclose service providers

Related plans

Similar-size Professional & Technical Services plans

BEACON THERAPEUTICS (USA), INC.

BEACON THERAPEUTICS (USA), INC. 401(K) PLAN

$6.7M · 56 participants

INVENRA INC.

INVENRA 401(K) PLAN

$6.6M · 63 participants

MONTE ROSA THERAPEUTICS INC

MONTE ROSA THERAPEUTICS, INC. 401(K) PLAN

$6.6M · 71 participants

PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY

PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY 403(B) PLAN

$6.7M · 23 participants

NOVUM PHARMACEUTICAL RESEARCH SE

NPRS, CO. 401K RETIREMENT PLAN